Share Prices & Company Research

Market News

28 Oct 2020 | 08:01

PureTech Health eyes Nasdaq listing for ADS

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health has filed a public registration statement to the US Securities and Exchange Commission as it looks to list its American depository shares on the Nasdaq. PureTech stated that in light of its "strong cash position", the potential US listing would not include the issuance or offering of any shares.

Following the listing, PureTech's American depository shares will trade on the Nasdaq Global Market, providing access for investors who prefer US-listed stocks.

However, the FTSE 250-listed firm added that it intends to maintain its premium listing on the Official List of the UK Financial Conduct Authority and trading on the main market of the London Stock Exchange.

As of 0915 GMT, PureTech shares were down 0.60% at 250.50p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 15th January 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.